Clinic
Shore Health System, INC
Shore Health System, INC was paid $5.28M by Medicaid between Jan 2018 and Dec 2024, across 145 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.
33Billing provider infoSHORE HEALTH SYSTEM, INC
EASTON, MD 21601
EASTON, MD 21601
33aNPI1669431219assigned 03/22/2006
33bProvider typeRadiology Clinic/Center
28Total paid$5.28M
24GClaims221,012
24DCodes billed145
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Radiology Clinic/Center providers in Maryland
Rank by total paid#1 of 9
Median peer was paid$204K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KOZEL, KENNETH controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,657 | $113K | |
| 2019 | 12,027 | $186K | |
| 2020 | 41,678 | $971K | |
| 2021 | 52,914 | $1.59M | |
| 2022 | 68,960 | $1.55M | |
| 2023 | 19,908 | $580K | |
| 2024incomplete | 11,868 | $290K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 7,018 | 6,122 | $808K |
| G0378 | Hospital observation service, per hour | 15% | 1,248 | 1,041 | $782K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 3,387 | 2,930 | $544K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.5% | 5,048 | 4,550 | $288K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5.4% | 2,906 | 1,869 | $285K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 5.4% | 4,295 | 3,432 | $284K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.7% | 2,926 | 2,643 | $194K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.5% | 3,908 | 3,503 | $187K |
| 80053 | Comprehensive metabolic panel | 3.1% | 20,342 | 15,464 | $164K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.6% | 2,863 | 2,322 | $136K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 22,736 | 16,302 | $123K |
| 80061 | Lipid panel | 2.2% | 5,149 | 4,274 | $115K |
133 more codes
| 88342 | 2.0% | 1,013 | $106K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 1,773 | $90K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.7% | 1,775 | $90K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 17,208 | $87K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 5,193 | $80K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 3,634 | $57K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,338 | $52K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,663 | $48K |
| 82728 | <1% | 1,711 | $44K | |
| 88142 | <1% | 1,999 | $40K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,239 | $39K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,242 | $39K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,157 | $34K |
| 82607 | <1% | 1,162 | $31K | |
| 84439 | <1% | 1,795 | $30K | |
| 86803 | <1% | 1,153 | $23K | |
| 85027 | <1% | 1,965 | $20K | |
| 83655 | <1% | 812 | $20K | |
| 82746 | <1% | 915 | $18K | |
| 87081 | <1% | 1,506 | $17K | |
| 83540 | <1% | 1,347 | $16K | |
| 80050 | General health panel | <1% | 1,834 | $15K |
| 87186 | <1% | 1,345 | $15K | |
| 83735 | <1% | 6,960 | $14K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 378 | $14K |
| 87077 | <1% | 1,433 | $13K | |
| 86787 | <1% | 809 | $13K | |
| 83550 | <1% | 898 | $13K | |
| 87070 | <1% | 1,084 | $11K | |
| 85610 | <1% | 2,927 | $11K | |
| 81001 | <1% | 5,844 | $10K | |
| 84466 | <1% | 321 | $10K | |
| 87340 | <1% | 1,161 | $10K | |
| 82570 | <1% | 1,067 | $10K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,018 | $9K |
| 86140 | <1% | 890 | $9K | |
| 80074 | <1% | 111 | $8K | |
| 83970 | <1% | 131 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 441 | $8K |
| 86592 | <1% | 1,484 | $8K | |
| 86850 | <1% | 1,248 | $8K | |
| 86762 | <1% | 877 | $8K | |
| 84480 | <1% | 376 | $8K | |
| 84702 | <1% | 380 | $7K | |
| 86703 | <1% | 640 | $6K | |
| 82043 | <1% | 534 | $6K | |
| 85652 | <1% | 1,134 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,444 | $6K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 400 | $5K |
| 80081 | <1% | 27 | $5K | |
| 86780 | <1% | 731 | $5K | |
| 82950 | <1% | 736 | $5K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 221 | $5K |
| 85730 | <1% | 1,698 | $4K | |
| 84153 | <1% | 145 | $4K | |
| 84403 | <1% | 100 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,099 | $4K |
| 86038 | <1% | 200 | $4K | |
| 84550 | <1% | 496 | $4K | |
| 83880 | <1% | 1,272 | $4K | |
| 84484 | <1% | 4,113 | $4K | |
| 82105 | <1% | 184 | $4K | |
| 94060 | <1% | 27 | $3K | |
| 85018 | <1% | 704 | $3K | |
| 85014 | <1% | 693 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,233 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,849 | $3K |
| 87147 | <1% | 540 | $3K | |
| 83516 | <1% | 144 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 19 | $3K |
| 86900 | <1% | 1,270 | $3K | |
| 86901 | <1% | 1,265 | $3K | |
| 87205 | <1% | 326 | $3K | |
| 84156 | <1% | 400 | $3K | |
| 82784 | <1% | 171 | $2K | |
| 80076 | <1% | 117 | $2K | |
| 94762 | <1% | 15 | $2K | |
| 86480 | <1% | 16 | $2K | |
| 84100 | <1% | 662 | $2K | |
| 94729 | <1% | 39 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 207 | $2K |
| 87507 | <1% | 23 | $2K | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,919 | $2K |
| 86003 | <1% | 38 | $2K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 47 | $2K |
| 83615 | <1% | 113 | $1K | |
| 83690 | <1% | 1,883 | $1K | |
| 82962 | <1% | 283 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16 | $858.47 |
| 82948 | <1% | 290 | $753.45 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 396 | $728.71 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 268 | $673.87 |
| 84146 | <1% | 14 | $643.92 | |
| 83001 | <1% | 13 | $617.40 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $564.99 |
| 84703 | <1% | 31 | $523.50 | |
| 81003 | <1% | 283 | $462.43 | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,898 | $445.69 |
| 86431 | <1% | 51 | $425.68 | |
| 94727 | <1% | 24 | $273.92 | |
| 82550 | <1% | 525 | $270.56 | |
| 87088 | <1% | 16 | $214.30 | |
| 82150 | <1% | 39 | $201.99 | |
| 87075 | <1% | 17 | $190.62 | |
| 86706 | <1% | 30 | $138.83 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 634 | $102.01 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,548 | $95.80 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 47 | $69.52 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,026 | $48.34 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 376 | $46.88 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 677 | $38.72 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,127 | $16.94 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,983 | $10.87 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 363 | $8.27 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 231 | $1.82 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 0% | 38 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 73 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 51 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 349 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 15 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 121 | $0.00 |
| 81329 | 0% | 41 | $0.00 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 145 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 982 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 431 | $0.00 |
| 87040 | 0% | 284 | $0.00 | |
| 83605 | 0% | 611 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 140 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 71 | $0.00 |
| 85379 | 0% | 43 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 15 | $0.00 |
| 82553 | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOZEL, KENNETH (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Shore Health System, INC. | Easton, MD | $1.17M |
| Shore Health System INC | Easton, MD | $1.07M |
| Chester River Hospital Center | Chestertown, MD | $627K |
| Shore Health System, INC | Easton, MD | $392K |
| Shore Health System, INC | Cambridge, MD | $349K |
| Chester River Hospital Center | Chestertown, MD | $137K |
| Shore Health System, INC | Cambridge, MD | $115K |
| Shore Health System, INC | Easton, MD | $57K |
| Shore Health System INC | Denton, MD | $40K |
| Um Shore Regional Health, INC | Chestertown, MD | $21K |
| Shore Health System, INC. | Easton, MD | $7K |
| Shore Health System, INC | Easton, MD | $3K |
| Shore Health System, INC | Queenstown, MD | $715.74 |
| Shore Health System, INC. | Easton, MD | $-0.04 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.